Skip to content

A study on Effectiveness of transcranial Direct Current Stimulation as an adjunct in Major Depressive disorder

EFFECTIVENESS OF TRANSCRANIAL DIRECT CURRENT STIMULATION AS AN ADD ON THERAPY IN MAJOR DEPRESSIVE DISORDER - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102789
Enrollment
60
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F329- Major depressive disorder, singleepisode, unspecified

Interventions

Intervention1: Active tDCS: Use of HD-tDCS device by Soterix medical Inc. To give active current of low intensity of 2 mA with anode placed over F3 and cathode over F4 for 30 minutes for 10 days(2 wee

Sponsors

VMMC and Safdarjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of Age range- 18-65 years newly Diagnosed with Major Depressive Disorder As per DSM-V TR Currently on SSRI mono-therapy willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Metal implant in head including intracranial electrodes, surgical clips, shrapnel or Implanted pacemaker in heart. History of Head injury resulting in loss of consciousness, history of Epilepsy or neurological disorders Concurrent use of other neuromodulation therapies like ECT, TMS Substance use disorder except nicotine and caffeine Pregnancy and lactation Patient with any other psychiatric comorbidity Patient with any medical comorbidity that are uncontrolled even on medication Unable to read and write Hindi / English

Design outcomes

Primary

MeasureTime frame
Change in depressive symptom severity, as measured by the Hamilton Depression Rating Scale (HDRS-17)Timepoint: at baseline and at end of 2 week tDCS session.

Secondary

MeasureTime frame
Change in anxiety symptoms, measured using the Hamilton Anxiety Rating Scale (HAM-A).Timepoint: Baseline to day 14 post intervention;Change in suicidal ideation, assessed by the Columbia Suicide Severity Rating Scale (C-SSR), Hindi version.Timepoint: Baseline at pre intervention to Day 14;Change in cognitive function, as measured by the Addenbrooke s Cognitive Examination III Hindi version (ACE-III Hindi).Timepoint: Baseline at pre intervention to Day 14

Countries

India

Contacts

Public ContactDr Brinda Shree

Vardhaman Mahavir medical college and Safdarjung Hospital

pverma_MD1@rediffmail.com9313534345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026